Superior efficacy of St John's wort extract WS®5570 compared to placebo in patients with major depression: A randomized, double-blind, placebo-controlled, multi-center trial [ISRCTN77277298]

BMC Medicine

Volumn 4, Issue , 2006, Pages

  Kasper, Siegfried ^a   Anghelescu, Ion George ^b   Szegedi, Armin ^b   Dienel, Angelika ^c   Kieser, Meinhard ^c  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c DR WILLMAR SCHWABE GMBH AND CO KG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HYPERICUM PERFORATUM EXTRACT; PLACEBO; UNCLASSIFIED DRUG; WS 5570;

ABDOMINAL PAIN; ACUTE STRESS DISORDER; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONNECTIVE TISSUE DISEASE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE EXACERBATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; EAR DISEASE; ECG ABNORMALITY; ERYTHEMA; EYE DISEASE; FEMALE; GASTROINTESTINAL DISEASE; GENITAL SYSTEM DISEASE; HAMILTON SCALE; HUMAN; INCIDENCE; INFECTION; INFESTATION; INJECTION SITE REACTION; INNER EAR DISEASE; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MEDIASTINUM DISEASE; MENTAL DISEASE; METABOLIC DISORDER; METRORRHAGIA; MULTICENTER STUDY; MUSCULOSKELETAL DISEASE; NEUROLOGIC DISEASE; NUTRITIONAL DISORDER; OUTPATIENT; PHOTOSENSITIVITY DISORDER; RANDOMIZED CONTROLLED TRIAL; REMISSION; RESPIRATORY TRACT DISEASE; SKIN DISEASE; STATISTICAL SIGNIFICANCE; STOMATITIS; SUICIDE ATTEMPT; THORAX DISEASE; TREATMENT OUTCOME; URINARY TRACT DISEASE; VASCULAR DISEASE;

ADOLESCENT; ADULT; AGED; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERICUM; MALE; MIDDLE AGED; PHYTOTHERAPY; PLANT EXTRACTS; SEVERITY OF ILLNESS INDEX;

EID: 33747180134     PISSN: 17417015     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/1741-7015-4-14     Document Type: Article

References (30)

1. Laakmann G, Dienel A, Kieser M: Clinical significance of hyperforin for the efficacy of Hypericum extracts on depressive disorders of different severities. Phytomedicine 1998, 5(6):435-442.
2. Laakmann G, Schüle C, Baghai T, Kieser M: St. John's wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy. Pharmacopsychiatry 1998, 31 (Suppl):54-59.
3. Kalb R, Trautmann-Sponsel RD, Kieser M: Efficacy and tolerability of Hypericum extract WS5572 versus placebo in mildly to moderately depressed patients. Pharmacopsychiatry 2001, 34:96-103.
4. Lecrubier Y, Clerc G, Didi R, Kieser M: Efficacy of St. John's wort extract WS5570 in major depression: a double-blind, placebo-controlled trial. Am J Psychiatry 2002, 159:1361-1366.
5. Vorbach EU, Arnoldt KH, Hübner WD: Efficacy and tolerability of St. John's Wort Extract LI 160 versus imipramine in patients with severe depressive episodes according to ICD-10. Pharmacopsychiatry 1997, 30:81-85.
6. Schrader E, Meier B, Brattström A: Hypericum treatment of mild-moderate depression in a placebo-controlled study. A prospective, double-blind, randomized, placebo-controlled, multicentre study. Hum Psychopharmacol 1998, 13:163-169.
7. Kasper S, Trautmann-Sponsel RD: St John's wort extract: an effective and well-tolerated antidepressant. Primary Care Psychiatry 2001, 7(1):39-42.
8. Linde K, Knüppell L: Large-scale observational studies of hypericum extracts in patients with depressive disorders-a systematic review. Phytomedicine 2005, 12:148-157.
9. Hübner WD, Lande S, Pozuweit H: Hypericum treatment of mild depressions with somatic symptoms. J Geriatr Psychiatry Neurol 1994, 7(Suppl 1): 12-14.
10. Sommer H, Harrer G: Placebo-controlled double-blind study examining the effectiveness of an Hypericum preparation in 105 mildly depressed patients. J Geriatr Psychiatry Neurol 1994, 7(Suppl 1):9-11.
11. Shelton RC, Keller MB, Gelenberg A, Dunner DL, Hirschfeld R, Thase ME, Russell J, Lydiard RB, Crits-Cristoph P, Gallop R, Todd L, Hellerstein D, Goodnick P, Keitner G, Stahl SM, Halbreich U: Effectiveness of St John's Wort in Major Depression. JAMA 2001, 285:1978-1986.
12. Hypericum Depression Trial Study Group: Effect of Hypericum perforatum (St John's Wort) in Major Depressive Disorder. JAMA 2002, 287:1807-1814.
13. Fava M, Alpert J, Nierenberger AA, Mischoulon D, Otto MW, Zajecka J, Murck H, Rosenbaum JF: A Double-blind, Randomized Trial of St John's Wort, Fluoxetine, and Placebo in Major Depressive Disorder. J Clin Psychopharmacol 2005, 25:441-447.
14. Linde K, Berner M, Egger M, Mulrow C: St John's wort for depression: Meta-analysis of randomised controlled trials. Br J Psychiatry 2005, 186:99-107.
15. Kasper S, Dienel A: Cluster analysis of symptoms during anti-depressant treatment with Hypericum extract in mildly to moderately depressed out-patients. A meta-analysis of data from three randomized, placebo-controlled trials. Psychopharmacology 2002, 164:301-308.
16. Linde K, Mulrow, CD, Berner M, Egger M: Śt John's wort for depression. Cochrane Database Syst Rev 2005, 2:CD000448.
17. Müller WE, Rolli M, Schäfer C, Hafner U: Effects of Hypericum extract (LI 160) in biochemical models of antidepressant activity. Pharmacopsychiatry 1997, 30(Suppl 2):S102-S107.
18. Perovic S, Müller WE: Pharmacological profile of Hypericum extract. Effect on serotonin uptake by postsynaptic receptors. Arzneimittelforschung 1995, 45:145-148.
19. Szegedi A, Kohnen R, Dienel A, Kieser M: Acute treatment of moderate to severe depression with hypericum extract WS5570 (St John's wort): randomised controlled double blind non-inferiority trial versus paroxetine. Br Med J 2005, 330:503-506.
20. German Federal Health Office (BGA) Monograph: Hyperici herba (St. John's Wort) Commission E monograph. Bundesanzeiger. 1984 Dec. 5
21. Rychlik R, Siedentop H, von den Driesch V, Kasper S: St. John's wort extract WS5572 in minor to moderately severe depression. Effectiveness and tolerance of 600 and 1200 mg ingredient daily. Fortschr Med Orig 2001, 119:119-128.
22. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders 4th edition. Washington, DC; 1994.
23. Linde K, Ramirez G, Mulrow CD, Pauls A, Weidenhammer W, Melchart D: St John's wort for depression-an overview and meta-analysis of randomized clinical trials. Br Med J 1996, 313:253-258.
24. Bauer P, Koehne K: Evaluation of experiments with adaptive interim analyses. Biometrics 1994, 50:1029-1041.
25. Bartholomew DJ: A test of homogeneity for ordered alternatives. Biometrika 1959, 46:36-48.
26. Bartholomew DJ: A test of homogeneity of means under restricted alternatives. Biometrika 1959, 46:328-335.
27. Phillips A: A review of the performance of tests used to establish whether there is a drug effect in dose-response studies. Drug Inf J 1998, 32:638-692.
28. o by pooled and separate-variances t tests given heterogeneity of sample variances. Communications in Statistics. Simulation and Computation 2004, 33:69-81.
29. Kieser M, Bauer P, Lehmacher W: Inference on multiple endpoints in clinical trials with adaptive interim analyses. Biom J 1999, 41:261-277.
30. Hammerness P, Basch E, Ulbricht C, Barette EP, Foppa I, Basch S, Bent S, Boon H, Ernst E: St. John's Wort: A Systematic Review of Adverse Effects and Drug Interactions for the Consultation Psychiatrist. Psychosomatics 2003, 44:271-282.